Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 145

1.

Increased chromosomal radiosensitivity in women carrying BRCA1/BRCA2 mutations assessed with the G2 assay.

Ernestos B, Nikolaos P, Koulis G, Eleni R, Konstantinos B, Alexandra G, Michael K.

Int J Radiat Oncol Biol Phys. 2010 Mar 15;76(4):1199-205. doi: 10.1016/j.ijrobp.2009.10.020.

PMID:
20206018
2.

Chromosomal radiosensitivity in BRCA1 and BRCA2 mutation carriers.

Baeyens A, Thierens H, Claes K, Poppe B, de Ridder L, Vral A.

Int J Radiat Biol. 2004 Oct;80(10):745-56.

PMID:
15799620
3.

BRCA1 and BRCA2 heterozygosity and repair of X-ray-induced DNA damage.

Nieuwenhuis B, Van Assen-Bolt AJ, Van Waarde-Verhagen MA, Sijmons RH, Van der Hout AH, Bauch T, Streffer C, Kampinga HH.

Int J Radiat Biol. 2002 Apr;78(4):285-95.

PMID:
12020440
4.

Chromosomal mutagen sensitivity associated with mutations in BRCA genes.

Speit G, Trenz K.

Cytogenet Genome Res. 2004;104(1-4):325-32. Review.

PMID:
15162060
5.

Ionizing radiation or mitomycin-induced micronuclei in lymphocytes of BRCA1 or BRCA2 mutation carriers.

Gutiérrez-Enríquez S, Ramón Y Cajal T, Alonso C, Corral A, Carrasco P, Cornet M, Sanz J, Ribas M, Baiget M, Diez O.

Breast Cancer Res Treat. 2011 Jun;127(3):611-22. doi: 10.1007/s10549-010-1017-6. Epub 2010 Jul 13.

PMID:
20625817
6.

Lymphocytes of BRCA1 and BRCA2 germ-line mutation carriers, with or without breast cancer, are not abnormally sensitive to the chromosome damaging effect of moderate folate deficiency.

Beetstra S, Salisbury C, Turner J, Altree M, McKinnon R, Suthers G, Fenech M.

Carcinogenesis. 2006 Mar;27(3):517-24. Epub 2005 Sep 14.

PMID:
16162645
7.

Skewed X chromosome inactivation and breast and ovarian cancer status: evidence for X-linked modifiers of BRCA1.

Lose F, Duffy DL, Kay GF, Kedda MA, Spurdle AB; Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer; Australian Ovarian Cancer Study Management Group.

J Natl Cancer Inst. 2008 Nov 5;100(21):1519-29. doi: 10.1093/jnci/djn345. Epub 2008 Oct 28.

PMID:
18957670
8.

Induced micronucleus frequencies in peripheral lymphocytes as a screening test for carriers of a BRCA1 mutation in breast cancer families.

Rothfuss A, Schütz P, Bochum S, Volm T, Eberhardt E, Kreienberg R, Vogel W, Speit G.

Cancer Res. 2000 Jan 15;60(2):390-4.

9.

A 24-color metaphase-based radiation assay discriminates heterozygous BRCA2 mutation carriers from controls by chromosomal radiosensitivity.

Becker AA, Graeser MK, Landwehr C, Hilger T, Baus W, Wappenschmidt B, Meindl A, Weber RG, Schmutzler RK.

Breast Cancer Res Treat. 2012 Aug;135(1):167-75. doi: 10.1007/s10549-012-2119-0. Epub 2012 Jun 23.

PMID:
22729890
10.

Mutagen sensitivity of peripheral blood from women carrying a BRCA1 or BRCA2 mutation.

Trenz K, Rothfuss A, Schütz P, Speit G.

Mutat Res. 2002 Mar 20;500(1-2):89-96.

PMID:
11890937
11.

Breast-feeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers.

Jernström H, Lubinski J, Lynch HT, Ghadirian P, Neuhausen S, Isaacs C, Weber BL, Horsman D, Rosen B, Foulkes WD, Friedman E, Gershoni-Baruch R, Ainsworth P, Daly M, Garber J, Olsson H, Sun P, Narod SA.

J Natl Cancer Inst. 2004 Jul 21;96(14):1094-8.

PMID:
15265971
12.

Genetic variations in DNA repair genes, radiosensitivity to cancer and susceptibility to acute tissue reactions in radiotherapy-treated cancer patients.

Chistiakov DA, Voronova NV, Chistiakov PA.

Acta Oncol. 2008;47(5):809-24. doi: 10.1080/02841860801885969. Review.

PMID:
18568480
13.

Evidence of haplotype insufficiency in human cells containing a germline mutation in BRCA1 or BRCA2.

Buchholz TA, Wu X, Hussain A, Tucker SL, Mills GB, Haffty B, Bergh S, Story M, Geara FB, Brock WA.

Int J Cancer. 2002 Feb 10;97(5):557-61.

14.

Mutation analysis of BRCA1 and BRCA2 cancer predisposition genes in radiation hypersensitive cancer patients.

Leong T, Whitty J, Keilar M, Mifsud S, Ramsay J, Birrell G, Venter D, Southey M, McKay M.

Int J Radiat Oncol Biol Phys. 2000 Nov 1;48(4):959-65.

PMID:
11072151
15.

Parity and the risk of breast and ovarian cancer in BRCA1 and BRCA2 mutation carriers.

Milne RL, Osorio A, Ramón y Cajal T, Baiget M, Lasa A, Diaz-Rubio E, de la Hoya M, Caldés T, Teulé A, Lázaro C, Blanco I, Balmaña J, Sánchez-Ollé G, Vega A, Blanco A, Chirivella I, Esteban Cardeñosa E, Durán M, Velasco E, Martínez de Dueñas E, Tejada MI, Miramar MD, Calvo MT, Guillén-Ponce C, Salazar R, San Román C, Urioste M, Benítez J.

Breast Cancer Res Treat. 2010 Jan;119(1):221-32. doi: 10.1007/s10549-009-0394-1. Epub 2009 Apr 16.

16.
17.

Effect of mammography on breast cancer risk in women with mutations in BRCA1 or BRCA2.

Goldfrank D, Chuai S, Bernstein JL, Ramon Y Cajal T, Lee JB, Alonso MC, Diez O, Baiget M, Kauff ND, Offit K, Robson M.

Cancer Epidemiol Biomarkers Prev. 2006 Nov;15(11):2311-3.

18.

Increased rates of chromosome breakage in BRCA1 carriers are normalized by oral selenium supplementation.

Kowalska E, Narod SA, Huzarski T, Zajaczek S, Huzarska J, Gorski B, Lubinski J.

Cancer Epidemiol Biomarkers Prev. 2005 May;14(5):1302-6.

19.
20.

Haplotype analysis of TP53 polymorphisms, Arg72Pro and Ins16, in BRCA1 and BRCA2 mutation carriers of French Canadian descent.

Cavallone L, Arcand SL, Maugard C, Ghadirian P, Mes-Masson AM, Provencher D, Tonin PN.

BMC Cancer. 2008 Apr 10;8:96. doi: 10.1186/1471-2407-8-96.

Supplemental Content

Support Center